Company news
ADMA Biologics Inc news in 2021
ADMA Biologics Inc's news releases, calls and decks from 2021, newest first.
ADMA Biologics Adopts Limited Duration Stockholder Rights Plan
December 20, 2021
ADMA Biologics Provides Update on Global Intellectual Property Portfolio
December 8, 2021
ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of Directors
November 16, 2021
ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SC
November 15, 2021
ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
November 9, 2021
ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021
November 2, 2021
ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 24, 2021
ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference
October 21, 2021
ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock
October 20, 2021
ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference
October 18, 2021
ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.
October 17, 2021
ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021
October 3, 2021
ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021
September 30, 2021
ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference
September 22, 2021
ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations
September 7, 2021
ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
September 1, 2021
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN
August 15, 2021
ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
August 10, 2021
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System
August 9, 2021
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®
August 8, 2021
ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021
August 3, 2021
ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection
July 19, 2021
ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference
June 13, 2021
ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference
May 25, 2021
ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments
May 11, 2021
ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021
May 4, 2021
ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale
April 27, 2021
ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.
April 25, 2021
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting
April 12, 2021
ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results
March 24, 2021
ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
March 17, 2021
ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit
March 3, 2021
ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections
March 2, 2021
ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting
February 25, 2021
ADMA Biologics to Participate in Raymond James Institutional Investor Conference
February 21, 2021
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
January 31, 2021
ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™
January 25, 2021
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook
January 18, 2021
ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™
January 3, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (December 2021)
Investor deck · 33 slides · Dec 1, 2021